Discover how Verve Therapeutics’ new patent for gene editing targeting the PCSK9 gene could revolutionize LDL cholesterol treatment and combat cardiovascular disease.
Proposed PFAS rule would cost companies estimated $1B; lacks limits and cleanup requirement
A proposed federal rule calls for forcing companies to disclose whether their products contain toxic “forever” chemicals, the government’s first attempt at cataloging the pervasiveness
July 10, 2023